Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Peptides for sleep may be the solution youve been searching for
Pregnancy & breastfeeding: Insufficient safety data exists
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Reviewed by Brandon Johnson Certified Personal Trainer, Nutrition Coach & Peptide Research Consultant Brandon Johnson is a certified personal trainer, nutrition coach, and peptide research consultant with a background in kinesiology and over 15 years of experience in fitness and wellness
Because there is no clinical or regulatory standard for human intake, researchers cannot calculate a bpc-157 and tb-500 dosage for injury repair based on personal wellness logs
US$ 21.05
US$ 29.72
US$ 22.76
US$ 24.29
US$ 22.65
US$ 29.53
US$ 28.85
